Deal Kya Hai? (The Block Deal Scoop)
Basically, Bain Capital ka ek affiliate, BC Investments IV Ltd, ne Emcure Pharma ke 18 lakh shares bech diye. Ye company ke total stake ka 0.95% banta hai. Deal hui ₹289.47 crore ki, aur share average ₹1,608.20 mein becha gaya. Iske baad Bain Capital ka Emcure mein stake 3.87% se kam hokar ab 2.93% ho gaya hai.
Market Ka Reaction? (Stock Ka Kya Hua?)
Jab ye news aayi toh market mein thoda sell-off dikha. Emcure ka share price 2.31% gir kar ₹1,690 par aa gaya tha NSE par. Investors thode worried the ki kya hoga.
Buyer Kaun Hai? (Who Stepped In?)
Achhi baat ye hai ki sell-off zyada nahi chala kyunki Norway ka Government Pension Fund Global, jo duniya ke sabse bade sovereign wealth funds mein se ek hai, ne same quantity mein shares same price par khareed liye. Toh yeh buying interest dikhata hai.
Emcure Ki Earnings? (Numbers Check)
Aur haan, agar aap Emcure ke financial results dekho toh wo kaafi impressive hain. December 2025 tak ke third quarter mein, company ne ₹231 crore ka consolidated profit after tax report kiya hai. Yeh pichhle saal ke ₹156 crore se 48% zyada hai. Revenue bhi ₹1,963 crore se badhkar ₹2,363 crore ho gaya. Toh company toh achha perform kar rahi hai.
Pehle Bhi Hui Hai Selling? (Bain's History)
Yeh pehli baar nahi hai jab Bain Capital ne Emcure mein apna stake kam kiya hai. Pichhle saal July 2025 mein bhi unhone 2.4% stake ₹563 crore mein becha tha.
